TMC-69

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameTMC-69
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionCell division cycle 25 phosphatase inhibitors
TargetsCell division cycle 25 phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A